nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromfenac—PTGS2—urinary bladder cancer	0.649	1	CbGaD
Bromfenac—PTGS2—Cisplatin—urinary bladder cancer	0.108	0.356	CbGbCtD
Bromfenac—PTGS2—Etoposide—urinary bladder cancer	0.106	0.349	CbGbCtD
Bromfenac—PTGS1—Etoposide—urinary bladder cancer	0.0897	0.295	CbGbCtD
Bromfenac—Suprofen—UGT2B7—urinary bladder cancer	0.00172	0.153	CrCbGaD
Bromfenac—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—urinary bladder cancer	0.0017	0.0505	CbGpPWpGaD
Bromfenac—PTGS2—Synthesis of 15-eicosatetraenoic acid derivatives—GPX1—urinary bladder cancer	0.00157	0.0467	CbGpPWpGaD
Bromfenac—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—urinary bladder cancer	0.00135	0.0401	CbGpPWpGaD
Bromfenac—PTGS1—Arachidonic acid metabolism—CYP4B1—urinary bladder cancer	0.00116	0.0343	CbGpPWpGaD
Bromfenac—Indomethacin—UGT2B7—urinary bladder cancer	0.0011	0.0975	CrCbGaD
Bromfenac—Tolmetin—CXCL8—urinary bladder cancer	0.00102	0.0904	CrCbGaD
Bromfenac—Diclofenac—UGT2B7—urinary bladder cancer	0.00099	0.0881	CrCbGaD
Bromfenac—Balsalazide—PPARG—urinary bladder cancer	0.000971	0.0864	CrCbGaD
Bromfenac—PTGS2—Arachidonic acid metabolism—CYP4B1—urinary bladder cancer	0.000917	0.0272	CbGpPWpGaD
Bromfenac—PTGS1—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.00081	0.024	CbGpPWpGaD
Bromfenac—Tolmetin—MPO—urinary bladder cancer	0.00079	0.0703	CrCbGaD
Bromfenac—PTGS2—C-MYB transcription factor network—PTCRA—urinary bladder cancer	0.000735	0.0218	CbGpPWpGaD
Bromfenac—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—GSTO2—urinary bladder cancer	0.000715	0.0212	CbGpPWpGaD
Bromfenac—Indomethacin—CXCL8—urinary bladder cancer	0.000619	0.0551	CrCbGaD
Bromfenac—PTGS1—Arachidonic acid metabolism—HPGDS—urinary bladder cancer	0.000615	0.0183	CbGpPWpGaD
Bromfenac—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—urinary bladder cancer	0.000593	0.0176	CbGpPWpGaD
Bromfenac—Diclofenac—CXCL8—urinary bladder cancer	0.000559	0.0498	CrCbGaD
Bromfenac—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—SLC19A1—urinary bladder cancer	0.000556	0.0165	CbGpPWpGaD
Bromfenac—PTGS1—Biological oxidations—GSTZ1—urinary bladder cancer	0.000551	0.0164	CbGpPWpGaD
Bromfenac—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—PRSS3—urinary bladder cancer	0.000542	0.0161	CbGpPWpGaD
Bromfenac—PTGS1—Biological oxidations—GSTO2—urinary bladder cancer	0.000522	0.0155	CbGpPWpGaD
Bromfenac—PTGS1—Biological oxidations—NAT1—urinary bladder cancer	0.000522	0.0155	CbGpPWpGaD
Bromfenac—PTGS2—Aryl Hydrocarbon Receptor—HPGDS—urinary bladder cancer	0.000522	0.0155	CbGpPWpGaD
Bromfenac—Ketoprofen—CXCL8—urinary bladder cancer	0.000495	0.0441	CrCbGaD
Bromfenac—PTGS2—Arachidonic acid metabolism—HPGDS—urinary bladder cancer	0.000488	0.0145	CbGpPWpGaD
Bromfenac—PTGS1—Biological oxidations—UGT2B7—urinary bladder cancer	0.000478	0.0142	CbGpPWpGaD
Bromfenac—PTGS1—Overview of nanoparticle effects—PTGS2—urinary bladder cancer	0.000464	0.0138	CbGpPWpGaD
Bromfenac—PTGS1—Overview of nanoparticle effects—CXCL8—urinary bladder cancer	0.00045	0.0134	CbGpPWpGaD
Bromfenac—PTGS1—Biological oxidations—CYP4B1—urinary bladder cancer	0.00043	0.0128	CbGpPWpGaD
Bromfenac—Indomethacin—PPARG—urinary bladder cancer	0.000428	0.0381	CrCbGaD
Bromfenac—PTGS2—Aryl Hydrocarbon Receptor—NQO1—urinary bladder cancer	0.00042	0.0125	CbGpPWpGaD
Bromfenac—Balsalazide—PTGS2—urinary bladder cancer	0.00041	0.0365	CrCbGaD
Bromfenac—PTGS2—S1P1 pathway—RHOA—urinary bladder cancer	0.000407	0.0121	CbGpPWpGaD
Bromfenac—PTGS1—Selenium Micronutrient Network—MPO—urinary bladder cancer	0.000386	0.0115	CbGpPWpGaD
Bromfenac—PTGS1—Eicosanoid Synthesis—PTGS2—urinary bladder cancer	0.000385	0.0114	CbGpPWpGaD
Bromfenac—Lumiracoxib—PTGS2—urinary bladder cancer	0.000375	0.0333	CrCbGaD
Bromfenac—PTGS2—C-MYB transcription factor network—BIRC3—urinary bladder cancer	0.000372	0.011	CbGpPWpGaD
Bromfenac—PTGS1—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.000364	0.0108	CbGpPWpGaD
Bromfenac—PTGS2—Overview of nanoparticle effects—CXCL8—urinary bladder cancer	0.000357	0.0106	CbGpPWpGaD
Bromfenac—Nepafenac—PTGS2—urinary bladder cancer	0.000357	0.0317	CrCbGaD
Bromfenac—Fenbufen—PTGS2—urinary bladder cancer	0.000341	0.0303	CrCbGaD
Bromfenac—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—urinary bladder cancer	0.000322	0.00957	CbGpPWpGaD
Bromfenac—PTGS2—C-MYB transcription factor network—MPO—urinary bladder cancer	0.000318	0.00945	CbGpPWpGaD
Bromfenac—PTGS2—Signaling mediated by p38-alpha and p38-beta—ESR1—urinary bladder cancer	0.000315	0.00935	CbGpPWpGaD
Bromfenac—PTGS1—Overview of nanoparticle effects—TNF—urinary bladder cancer	0.000313	0.00931	CbGpPWpGaD
Bromfenac—PTGS2—Selenium Micronutrient Network—MPO—urinary bladder cancer	0.000307	0.0091	CbGpPWpGaD
Bromfenac—Tolmetin—PTGS2—urinary bladder cancer	0.000296	0.0264	CrCbGaD
Bromfenac—PTGS2—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.000289	0.00857	CbGpPWpGaD
Bromfenac—PTGS1—Biological oxidations—NAT2—urinary bladder cancer	0.000286	0.0085	CbGpPWpGaD
Bromfenac—Suprofen—PTGS2—urinary bladder cancer	0.000284	0.0253	CrCbGaD
Bromfenac—PTGS2—Aryl Hydrocarbon Receptor—ESR1—urinary bladder cancer	0.000253	0.00752	CbGpPWpGaD
Bromfenac—PTGS2—Overview of nanoparticle effects—TNF—urinary bladder cancer	0.000249	0.00739	CbGpPWpGaD
Bromfenac—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—urinary bladder cancer	0.000244	0.00723	CbGpPWpGaD
Bromfenac—PTGS1—Selenium Micronutrient Network—SOD2—urinary bladder cancer	0.000242	0.0072	CbGpPWpGaD
Bromfenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—urinary bladder cancer	0.000238	0.00706	CbGpPWpGaD
Bromfenac—PTGS1—Selenium Micronutrient Network—GPX1—urinary bladder cancer	0.000231	0.00687	CbGpPWpGaD
Bromfenac—PTGS1—Biological oxidations—HPGDS—urinary bladder cancer	0.000229	0.00679	CbGpPWpGaD
Bromfenac—PTGS1—Biological oxidations—GSTT1—urinary bladder cancer	0.000222	0.00659	CbGpPWpGaD
Bromfenac—PTGS2—Aryl Hydrocarbon Receptor—RB1—urinary bladder cancer	0.000221	0.00656	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—LIG1—urinary bladder cancer	0.000219	0.0065	CbGpPWpGaD
Bromfenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—urinary bladder cancer	0.000216	0.00641	CbGpPWpGaD
Bromfenac—PTGS1—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000214	0.00636	CbGpPWpGaD
Bromfenac—PTGS1—Selenium Micronutrient Network—MTHFR—urinary bladder cancer	0.000213	0.00634	CbGpPWpGaD
Bromfenac—PTGS2—C-MYB transcription factor network—GSTM1—urinary bladder cancer	0.000199	0.00591	CbGpPWpGaD
Bromfenac—PTGS2—C-MYB transcription factor network—NCOR1—urinary bladder cancer	0.000199	0.00591	CbGpPWpGaD
Bromfenac—PTGS2—Selenium Micronutrient Network—SOD2—urinary bladder cancer	0.000192	0.00572	CbGpPWpGaD
Bromfenac—PTGS2—Selenium Micronutrient Network—GPX1—urinary bladder cancer	0.000184	0.00545	CbGpPWpGaD
Bromfenac—Indomethacin—PTGS2—urinary bladder cancer	0.000181	0.0161	CrCbGaD
Bromfenac—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—urinary bladder cancer	0.000171	0.00508	CbGpPWpGaD
Bromfenac—PTGS2—Selenium Micronutrient Network—MTHFR—urinary bladder cancer	0.000169	0.00503	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	0.000167	0.00496	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	0.000166	0.00493	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000165	0.0049	CbGpPWpGaD
Bromfenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—urinary bladder cancer	0.000165	0.00489	CbGpPWpGaD
Bromfenac—Diclofenac—PTGS2—urinary bladder cancer	0.000163	0.0145	CrCbGaD
Bromfenac—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	0.000159	0.00472	CbGpPWpGaD
Bromfenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—urinary bladder cancer	0.000157	0.00468	CbGpPWpGaD
Bromfenac—PTGS1—prostate gland—urinary bladder cancer	0.000157	0.0904	CbGeAlD
Bromfenac—PTGS1—Biological oxidations—GSTP1—urinary bladder cancer	0.000154	0.00457	CbGpPWpGaD
Bromfenac—PTGS2—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	0.000151	0.00449	CbGpPWpGaD
Bromfenac—PTGS2—prostate gland—urinary bladder cancer	0.00015	0.0864	CbGeAlD
Bromfenac—PTGS2—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	0.000147	0.00436	CbGpPWpGaD
Bromfenac—Ketoprofen—PTGS2—urinary bladder cancer	0.000145	0.0129	CrCbGaD
Bromfenac—PTGS1—Biological oxidations—GSTM1—urinary bladder cancer	0.000141	0.0042	CbGpPWpGaD
Bromfenac—PTGS2—C-MYB transcription factor network—CREBBP—urinary bladder cancer	0.000137	0.00407	CbGpPWpGaD
Bromfenac—PTGS1—Selenium Micronutrient Network—PTGS2—urinary bladder cancer	0.000136	0.00404	CbGpPWpGaD
Bromfenac—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—urinary bladder cancer	0.000135	0.004	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	0.000134	0.00397	CbGpPWpGaD
Bromfenac—PTGS1—seminal vesicle—urinary bladder cancer	0.000133	0.0765	CbGeAlD
Bromfenac—PTGS2—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	0.000132	0.00391	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000131	0.00389	CbGpPWpGaD
Bromfenac—PTGS2—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	0.000129	0.00382	CbGpPWpGaD
Bromfenac—PTGS2—seminal vesicle—urinary bladder cancer	0.000127	0.0731	CbGeAlD
Bromfenac—PTGS2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	0.000123	0.00364	CbGpPWpGaD
Bromfenac—PTGS2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	0.000122	0.00361	CbGpPWpGaD
Bromfenac—PTGS2—C-MYB transcription factor network—CDKN2A—urinary bladder cancer	0.00012	0.00356	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—CDK4—urinary bladder cancer	0.00012	0.00355	CbGpPWpGaD
Bromfenac—PTGS1—epithelium—urinary bladder cancer	0.000115	0.0664	CbGeAlD
Bromfenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—urinary bladder cancer	0.000115	0.00341	CbGpPWpGaD
Bromfenac—PTGS1—smooth muscle tissue—urinary bladder cancer	0.000111	0.064	CbGeAlD
Bromfenac—PTGS2—epithelium—urinary bladder cancer	0.00011	0.0635	CbGeAlD
Bromfenac—PTGS1—renal system—urinary bladder cancer	0.000107	0.0616	CbGeAlD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	0.000106	0.00316	CbGpPWpGaD
Bromfenac—PTGS2—smooth muscle tissue—urinary bladder cancer	0.000106	0.0612	CbGeAlD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	0.000104	0.0031	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—RB1—urinary bladder cancer	0.000104	0.00309	CbGpPWpGaD
Bromfenac—PTGS2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	0.000103	0.00307	CbGpPWpGaD
Bromfenac—PTGS2—renal system—urinary bladder cancer	0.000102	0.0589	CbGeAlD
Bromfenac—PTGS2—C-MYB transcription factor network—CCND1—urinary bladder cancer	0.000101	0.00301	CbGpPWpGaD
Bromfenac—PTGS2—urethra—urinary bladder cancer	0.0001	0.0578	CbGeAlD
Bromfenac—PTGS2—C-MYB transcription factor network—CDKN1A—urinary bladder cancer	9.81e-05	0.00291	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—RHOA—urinary bladder cancer	9.44e-05	0.0028	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—GSTZ1—urinary bladder cancer	9.42e-05	0.0028	CbGpPWpGaD
Bromfenac—PTGS2—C-MYB transcription factor network—EP300—urinary bladder cancer	9.33e-05	0.00277	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	9.25e-05	0.00275	CbGpPWpGaD
Bromfenac—PTGS1—Selenium Micronutrient Network—TNF—urinary bladder cancer	9.19e-05	0.00273	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—GSTO2—urinary bladder cancer	8.93e-05	0.00265	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—NAT1—urinary bladder cancer	8.93e-05	0.00265	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	8.78e-05	0.00261	CbGpPWpGaD
Bromfenac—PTGS1—female reproductive system—urinary bladder cancer	8.55e-05	0.0493	CbGeAlD
Bromfenac—PTGS2—Disease—GSTO2—urinary bladder cancer	8.47e-05	0.00251	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—CXCL8—urinary bladder cancer	8.29e-05	0.00246	CbGpPWpGaD
Bromfenac—PTGS2—female reproductive system—urinary bladder cancer	8.18e-05	0.0472	CbGeAlD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	8.17e-05	0.00243	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—UGT2B7—urinary bladder cancer	8.17e-05	0.00243	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	8.14e-05	0.00242	CbGpPWpGaD
Bromfenac—PTGS2—C-MYB transcription factor network—MYC—urinary bladder cancer	8.13e-05	0.00241	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	8.1e-05	0.00241	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—IL2—urinary bladder cancer	7.92e-05	0.00235	CbGpPWpGaD
Bromfenac—PTGS1—vagina—urinary bladder cancer	7.74e-05	0.0446	CbGeAlD
Bromfenac—PTGS2—Spinal Cord Injury—CCND1—urinary bladder cancer	7.72e-05	0.00229	CbGpPWpGaD
Bromfenac—PTGS2—C-MYB transcription factor network—KRAS—urinary bladder cancer	7.51e-05	0.00223	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—MMP9—urinary bladder cancer	7.5e-05	0.00223	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—GSTZ1—urinary bladder cancer	7.48e-05	0.00222	CbGpPWpGaD
Bromfenac—PTGS2—vagina—urinary bladder cancer	7.39e-05	0.0427	CbGeAlD
Bromfenac—PTGS1—Metabolism—CYP4B1—urinary bladder cancer	7.35e-05	0.00218	CbGpPWpGaD
Bromfenac—PTGS2—Selenium Micronutrient Network—TNF—urinary bladder cancer	7.3e-05	0.00217	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	7.1e-05	0.00211	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—GSTO2—urinary bladder cancer	7.09e-05	0.00211	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—NAT1—urinary bladder cancer	7.09e-05	0.00211	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	7.01e-05	0.00208	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	6.97e-05	0.00207	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—SLC19A1—urinary bladder cancer	6.94e-05	0.00206	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—PRSS3—urinary bladder cancer	6.77e-05	0.00201	CbGpPWpGaD
Bromfenac—PTGS2—Disease—SLC19A1—urinary bladder cancer	6.58e-05	0.00195	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—UGT2B7—urinary bladder cancer	6.48e-05	0.00193	CbGpPWpGaD
Bromfenac—PTGS2—Disease—PRSS3—urinary bladder cancer	6.42e-05	0.00191	CbGpPWpGaD
Bromfenac—PTGS2—C-MYB transcription factor network—HRAS—urinary bladder cancer	6.39e-05	0.0019	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—MYC—urinary bladder cancer	6.2e-05	0.00184	CbGpPWpGaD
Bromfenac—PTGS2—Disease—HDAC4—urinary bladder cancer	6.12e-05	0.00182	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—EGFR—urinary bladder cancer	6.06e-05	0.0018	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	5.95e-05	0.00177	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—CYP4B1—urinary bladder cancer	5.84e-05	0.00173	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—TNF—urinary bladder cancer	5.77e-05	0.00171	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—SLC19A1—urinary bladder cancer	5.51e-05	0.00164	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	5.43e-05	0.00161	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—TYMP—urinary bladder cancer	5.41e-05	0.00161	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—PRSS3—urinary bladder cancer	5.37e-05	0.0016	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	5.25e-05	0.00156	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	5.2e-05	0.00154	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—TP53—urinary bladder cancer	5.09e-05	0.00151	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	5.08e-05	0.00151	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	5.07e-05	0.00151	CbGpPWpGaD
Bromfenac—PTGS1—lymph node—urinary bladder cancer	5e-05	0.0289	CbGeAlD
Bromfenac—PTGS1—Metabolism—NAT2—urinary bladder cancer	4.89e-05	0.00145	CbGpPWpGaD
Bromfenac—PTGS2—Disease—LIG1—urinary bladder cancer	4.86e-05	0.00144	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	4.84e-05	0.00144	CbGpPWpGaD
Bromfenac—PTGS2—lymph node—urinary bladder cancer	4.78e-05	0.0276	CbGeAlD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	4.7e-05	0.0014	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	4.31e-05	0.00128	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—TYMP—urinary bladder cancer	4.3e-05	0.00128	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—RRM2—urinary bladder cancer	4.22e-05	0.00125	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	4.21e-05	0.00125	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	4.13e-05	0.00123	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	4.12e-05	0.00122	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	3.93e-05	0.00117	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—ENO2—urinary bladder cancer	3.91e-05	0.00116	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—HPGDS—urinary bladder cancer	3.91e-05	0.00116	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	3.89e-05	0.00116	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.89e-05	0.00115	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—NAT2—urinary bladder cancer	3.88e-05	0.00115	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—GSTT1—urinary bladder cancer	3.79e-05	0.00113	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.74e-05	0.00111	CbGpPWpGaD
Bromfenac—PTGS2—Disease—ENO2—urinary bladder cancer	3.71e-05	0.0011	CbGpPWpGaD
Bromfenac—PTGS2—Disease—RBX1—urinary bladder cancer	3.52e-05	0.00104	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	3.46e-05	0.00103	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—RRM2—urinary bladder cancer	3.35e-05	0.000996	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—NQO1—urinary bladder cancer	3.15e-05	0.000936	CbGpPWpGaD
Bromfenac—PTGS2—Disease—JAG1—urinary bladder cancer	3.15e-05	0.000934	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—HPGDS—urinary bladder cancer	3.11e-05	0.000922	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—ENO2—urinary bladder cancer	3.11e-05	0.000922	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.09e-05	0.000917	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.06e-05	0.000908	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—GSTT1—urinary bladder cancer	3.01e-05	0.000894	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.97e-05	0.000881	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.67e-05	0.000792	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—GSTP1—urinary bladder cancer	2.63e-05	0.000781	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.54e-05	0.000756	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—NQO1—urinary bladder cancer	2.5e-05	0.000743	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—TYMS—urinary bladder cancer	2.44e-05	0.000726	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—NCOR1—urinary bladder cancer	2.42e-05	0.000718	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—GSTM1—urinary bladder cancer	2.42e-05	0.000718	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—GPX1—urinary bladder cancer	2.31e-05	0.000687	CbGpPWpGaD
Bromfenac—PTGS2—Disease—NCOR1—urinary bladder cancer	2.29e-05	0.00068	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—ERCC2—urinary bladder cancer	2.27e-05	0.000675	CbGpPWpGaD
Bromfenac—PTGS2—Disease—ERCC2—urinary bladder cancer	2.15e-05	0.00064	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—MTHFR—urinary bladder cancer	2.14e-05	0.000634	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.12e-05	0.000629	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—GSTP1—urinary bladder cancer	2.09e-05	0.00062	CbGpPWpGaD
Bromfenac—PTGS2—Disease—MTHFR—urinary bladder cancer	2.02e-05	0.000601	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.02e-05	0.0006	CbGpPWpGaD
Bromfenac—PTGS2—Disease—TERT—urinary bladder cancer	2.02e-05	0.0006	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—TYMS—urinary bladder cancer	1.94e-05	0.000576	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—GSTM1—urinary bladder cancer	1.92e-05	0.00057	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—NCOR1—urinary bladder cancer	1.92e-05	0.00057	CbGpPWpGaD
Bromfenac—PTGS2—Disease—FGFR3—urinary bladder cancer	1.85e-05	0.00055	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—GPX1—urinary bladder cancer	1.84e-05	0.000546	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—ERCC2—urinary bladder cancer	1.8e-05	0.000536	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—PPARG—urinary bladder cancer	1.73e-05	0.000514	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—MTHFR—urinary bladder cancer	1.7e-05	0.000504	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—CREBBP—urinary bladder cancer	1.66e-05	0.000494	CbGpPWpGaD
Bromfenac—PTGS2—Disease—CREBBP—urinary bladder cancer	1.58e-05	0.000468	CbGpPWpGaD
Bromfenac—PTGS2—Disease—RHOA—urinary bladder cancer	1.43e-05	0.000424	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—PPARG—urinary bladder cancer	1.37e-05	0.000408	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—PTGS2—urinary bladder cancer	1.36e-05	0.000405	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—CREBBP—urinary bladder cancer	1.32e-05	0.000392	CbGpPWpGaD
Bromfenac—PTGS2—Disease—ERBB2—urinary bladder cancer	1.32e-05	0.000392	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—PTEN—urinary bladder cancer	1.19e-05	0.000353	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—EP300—urinary bladder cancer	1.13e-05	0.000336	CbGpPWpGaD
Bromfenac—PTGS2—Disease—CDKN1A—urinary bladder cancer	1.13e-05	0.000335	CbGpPWpGaD
Bromfenac—PTGS2—Disease—PTEN—urinary bladder cancer	1.13e-05	0.000334	CbGpPWpGaD
Bromfenac—PTGS2—Disease—EP300—urinary bladder cancer	1.07e-05	0.000319	CbGpPWpGaD
Bromfenac—PTGS2—Disease—SRC—urinary bladder cancer	1.04e-05	0.00031	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—PTEN—urinary bladder cancer	9.43e-06	0.00028	CbGpPWpGaD
Bromfenac—PTGS2—Disease—MYC—urinary bladder cancer	9.36e-06	0.000278	CbGpPWpGaD
Bromfenac—PTGS2—Disease—EGFR—urinary bladder cancer	9.15e-06	0.000272	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—EP300—urinary bladder cancer	9e-06	0.000267	CbGpPWpGaD
Bromfenac—PTGS2—Disease—KRAS—urinary bladder cancer	8.65e-06	0.000257	CbGpPWpGaD
Bromfenac—PTGS2—Disease—HRAS—urinary bladder cancer	7.35e-06	0.000218	CbGpPWpGaD
